BioMark Diagnostics, Inc. (BUX.CX)
0.64
+0.06
(+10.34%)
CAD |
CNSX |
Mar 03, 15:51
BioMark Diagnostics Market Cap : 67.26M for March 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Justera Health Ltd. | 0.5024M |
| Neural Therapeutics, Inc. | 3.374M |
| ARCpoint, Inc. | 1.284M |
| Arch Biopartners, Inc. | 54.22M |
| Biocure Technology, Inc. | 0.7072M |
Market Cap Related Metrics
| PS Ratio | 526.62 |
| Price to Book Value | 77.86 |
| Price | 0.64 |
| Earnings Yield | -2.55% |